Case Studies

Medicago Inc. : From IPO to a $357 million sale

Medicago was a clinical-stage biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs).

Medicago was acquired by Mitsibushi Tanabe Pharma in July 2013 for approximately CAD $357,000,000.

Read more...